SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-033455
Filing Date
2024-03-19
Accepted
2024-03-19 16:05:53
Documents
13
Period of Report
2024-03-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tyra-20240319.htm   iXBRL 8-K 40265
2 EX-99.1 tyra-ex99_1.htm EX-99.1 136481
3 GRAPHIC img74818929_0.jpg GRAPHIC 343779
  Complete submission text file 0000950170-24-033455.txt   703104

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tyra-20240319.xsd EX-101.SCH 24808
16 EXTRACTED XBRL INSTANCE DOCUMENT tyra-20240319_htm.xml XML 4701
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

IRS No.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40800 | Film No.: 24763061
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)